You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 5,633,272


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,633,272
Title: Substituted isoxazoles for the treatment of inflammation
Abstract:A class of substituted isoxazolyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II ##STR1## wherein R.sup.1 is selected from hydroxyl, lower alkyl, carboxyl, lower carboxyalkyl, lower aminocarbonylalkyl, lower alkoxycarbonylalkyl, lower aralkyl, lower alkoxyalkyl, lower aralkoxyalkyl, lower alkylthioalkyl, lower aralkylthioalkyl, lower alkylaminoalkyl, lower aryloxyalkyl, lower arylthioalkyl, lower haloalkyl, lower hydroxylalkyl, cycloalkyl, cycloalkylalkyl, and aralkyl; wherein R.sup.3 is selected from cycloalkyl, cycloalkenyl, aryl, and heteroaryl; wherein R.sup.3 is optionally substituted at a substitutable position with one or more radicals independently selected from lower alkylsulfinyl, lower alkyl, cyano, carboxyl, lower alkoxycarbonyl, lower haloalkyl, hydroxyl, lower hydroxyalkyl, lower haloalkoxy, amino, lower alkylamino, lower arylamino, lower aminoalkyl, nitro, halo, lower alkoxy, aminosulfonyl, and lower alkylthio; and wherein R.sup.4 is selected from lower alkyl, hydroxyl and amino; or a pharmaceutically-acceptable salt thereof.
Inventor(s): Talley; John J. (Brentwood, MO), Brown; David L. (Chesterfield, MO), Nagarajan; Srinivasan (Chesterfield, MO), Carter; Jeffery S. (Chesterfield, MO), Weier; Richard M. (Lake Bluff, IL), Stealey; Michael A. (Libertyville, IL), Collins; Paul W. (Deerfield, IL), Rogers, deceased; Roland S. (late of Richmond Heights, MO), Seibert; Karen (St. Louis, MO)
Assignee:
Application Number:08/473,884
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

United States Patent 5,633,272: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 5,633,272, titled "Substituted isoxazoles for the treatment of inflammation," is a significant patent in the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication and Authority

The patent, US5633272A, was granted by the United States Patent and Trademark Office (USPTO) and is now expired, having completed its lifetime[4].

Inventive Subject Matter

The patent describes a class of substituted isoxazolyl compounds designed for the treatment of inflammation and inflammation-related disorders. These compounds are highlighted for their anti-inflammatory properties with minimal side effects.

Scope of the Patent

Claim Analysis

The scope of a patent is largely defined by its claims. For US5633272A, the claims specify the chemical structure and composition of the substituted isoxazoles, including their functional groups and molecular arrangements. Here are some key aspects:

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might specify a general formula for the substituted isoxazoles, while subsequent claims narrow down to specific embodiments or variations of the compounds[4].

  • Dependent Claims: These claims build upon the independent claims, providing more detailed descriptions of specific aspects of the invention, such as particular substituents or methods of preparation.

Metrics for Patent Scope

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims, as seen in this patent, are often associated with a higher probability of grant and a shorter examination process[3].

Claims and Their Significance

Chemical Structure

The claims in US5633272A focus on the specific chemical structures of the substituted isoxazoles. For instance, the patent mentions compounds such as 3-(2-hydroxyphenyl)isoxazoles and 5-piperazinyl-3,4-diaryl-isoxazoles, which are known for their anti-inflammatory properties[4].

Therapeutic Use

The claims also emphasize the therapeutic use of these compounds, specifically their application in treating inflammatory disorders. This includes conditions such as arthritis, where these compounds can act as cyclooxygenase inhibitors, reducing inflammation.

Prior Art and Related Patents

International Context

The patent landscape for anti-inflammatory agents is rich with prior art. For example, European Patent EP 26928 describes 3,4-diaryl-isoxazole-5-acetic acids with anti-inflammatory activity, while World Intellectual Property Organization (WIPO) publications WO 92/05162 and WO 92/19604 discuss similar compounds with medicinal use[4].

Domestic Context

In the United States, other patents and patent applications have also addressed similar anti-inflammatory compounds. For instance, the dispersible formulation of an anti-inflammatory agent described in US-2005004098-A1 shows the ongoing innovation in this field[5].

Patent Search and Analysis Tools

To understand the broader patent landscape, several tools and resources are available:

  • Patent Public Search: This tool, provided by the USPTO, allows for comprehensive searches of prior art and related patents. It replaces legacy tools like PubEast and PubWest and offers enhanced access to prior art[1].

  • Global Dossier: This service provides access to the file histories of related applications from participating IP Offices, helping to identify patent families and related citations[1].

  • Common Citation Document (CCD): This application consolidates citation data from multiple IP Offices, facilitating a more integrated view of the global patent landscape[1].

Impact on Innovation and Litigation

Patent Quality and Scope

The debate over patent quality often revolves around the breadth and clarity of patent claims. Patents with narrower, clearer claims, like those in US5633272A, are generally seen as more valid and less likely to lead to litigation. This is because they provide a clearer boundary of what is protected, reducing the likelihood of overlapping claims and disputes[3].

Licensing and Litigation Costs

Broader or overly broad patents can increase licensing and litigation costs, potentially stifling innovation. In contrast, patents with well-defined claims, such as US5633272A, can facilitate more efficient licensing and reduce the risk of costly legal battles.

Conclusion

United States Patent 5,633,272 represents a significant contribution to the field of anti-inflammatory treatments. The patent's scope, defined by its claims, highlights specific substituted isoxazolyl compounds with therapeutic applications. Understanding this patent within the broader patent landscape, using tools like the Patent Public Search and Global Dossier, is crucial for innovators and legal practitioners alike.

Key Takeaways

  • Specific Claims: The patent's claims are narrowly defined, specifying the chemical structures and therapeutic uses of the substituted isoxazoles.
  • Prior Art: The invention builds upon a rich prior art landscape, including international and domestic patents related to anti-inflammatory agents.
  • Patent Tools: Utilizing tools like Patent Public Search and Global Dossier can help in understanding the patent's position within the global patent landscape.
  • Impact on Innovation: Narrower, clearer claims can reduce litigation costs and facilitate innovation by providing clear boundaries of protection.

FAQs

What is the main subject matter of US Patent 5,633,272?

The main subject matter is a class of substituted isoxazolyl compounds used for the treatment of inflammation and inflammation-related disorders.

How can one search for related patents to US5633272A?

One can use the USPTO's Patent Public Search tool or the Global Dossier service to search for related patents and understand the broader patent landscape.

What are the benefits of narrower patent claims?

Narrower patent claims are associated with a higher probability of grant, a shorter examination process, and reduced litigation costs, as they provide clearer boundaries of protection.

How does prior art influence the scope of a patent?

Prior art can limit the scope of a patent by establishing what is already known in the field, thus requiring the patent claims to be more specific and innovative to be granted.

What tools are available for analyzing the global patent landscape?

Tools such as the Patent Public Search, Global Dossier, and Common Citation Document (CCD) are available for analyzing the global patent landscape and understanding the position of a patent within it.

Sources

  1. USPTO: Search for patents - USPTO.
  2. ACUS: U.S. Patent Small Claims Court.
  3. SSRN: Patent Claims and Patent Scope.
  4. Google Patents: US5633272A - Substituted isoxazoles for the treatment of inflammation.
  5. PubChem: Dispersible formulation of an anti-inflammatory agent - Patent US-2005004098-A1.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 5,633,272

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 5,633,272

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 0809636 ⤷  Try for Free SPC011/2003 Ireland ⤷  Try for Free
European Patent Office 0809636 ⤷  Try for Free 91024 Luxembourg ⤷  Try for Free
European Patent Office 0809636 ⤷  Try for Free 300128 Netherlands ⤷  Try for Free
European Patent Office 0809636 ⤷  Try for Free SPC/GB03/022 United Kingdom ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.